Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Andrew Sokolow

3PUBLICATIONS

20CO-AUTHORS

Medical bacteriologyInfant and child health

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Sep 30, 2024

Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients With Cystic Fibrosis.

Stephanie L Rolsma, Andrew Sokolow, Pratish C Patel

|Jan 26, 2024

Longitudinal profiling of the intestinal microbiome in children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor.

Seth A Reasoner, Rachel Bernard, Adam Waalkes

|Aug 30, 2023

Longitudinal Profiling of the Intestinal Microbiome in Children with Cystic Fibrosis Treated with Elexacaftor-Tezacaftor-Ivacaftor.

Seth A Reasoner, Rachel Bernard, Adam Waalkes

Pageof 1

Frequent Collaborators

2 joint publications

Seth A Reasoner

2 joint publications

Rachel Bernard

2 joint publications

Adam Waalkes

2 joint publications

Rebekah F Brown

2 joint publications

Kathryn M Edwards

2 joint publications

Stephen J Salipante

2 joint publications

Maria Hadjifrangiskou

2 joint publications

Maribeth R Nicholson

1 joint publications

Kelsi Penewit

1 joint publications

Stephanie L Rolsma

Frequent Collaborators

2 joint publications

Seth A Reasoner

2 joint publications

Rachel Bernard

2 joint publications

Adam Waalkes

2 joint publications

Rebekah F Brown

Top Related Videos

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Published on : Apr 18, 2025

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

See more related videos

Top Related Videos

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Published on : Apr 18, 2025

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

See more related videos